Extramedullary plasmacytoma and solitary plasmacytoma represent rare manifestations of plasma cell dyscrasias, where abnormal plasma cells accumulate as a single localised lesion. In the case of ...

Randomized Phase II Placebo-Controlled Trial of Maintenance Therapy Using the Oral Triple Angiokinase Inhibitor BIBF 1120 After Chemotherapy for Relapsed Ovarian Cancer We provide an overview on ...

The incidence of multiple myeloma, solitary plasmacytoma, and extramedullary plasmacytoma has increased between 2003 and 2016. The rate of mortality for multiple myeloma decreased over that same ...

ORLANDO -- For triple-class exposed relapsed or refractory multiple myeloma with extramedullary disease (EMD), a combination of talquetamab (Talvey) and teclistamab (Tecvayli) achieved high response ...

In patients with extramedullary plasmacytoma of the head and neck, radiotherapy and surgery provide comparable survival outcomes, but radiotherapy significantly reduced the risk for progression to ...

Please provide your email address to receive an email when new articles are posted on . In this interview Shahzad Raza, MD, discusses a study on the treatment of patients with extramedullary myeloma, ...

The United States is becoming older, more diverse, and more overweight, and these changes may influence future trends in certain hematological cancers. A recent study examining trends in incidence ...

Multiple myeloma (MM) is a highly heterogenous disease, with 63 known recurrent driving mutations. Despite the availability of numerous approved drugs for this malignancy, this cancer exhibits ...